startup
Houdini Bio emerges from stealth with €1.7 million to tackle DNA silencing in gene therapies
Source:
eu-startups.com 1 min read
Share
You are reading a summary. The full content is hosted on eu-startups.com.
British BioTech startup Houdini Bio has exited out of stealth today with approximately €1.7 million (£1.5 million) in pre-Seed funding in order to validate its DNA sequence design infrastructure platform – engineered to overcome the biological barriers limiting genetic medicines. The round was led by SCVC (the venture arm of Science Creates), with participation from Deep […] The post Houdini Bio emerges from stealth with €1.7 million to tackle DNA silencing in gene therapies appeared first on EU-Startups.
Read the full article on the original website
External link to eu-startups.com
Related Articles
startup
Investigation: Polymarket is paying creators to make deceptive videos about winning bets, targeting users in the US, where its primary crypto platform is banned (Wall Street Journal)
1 min read •
startup
Brazil takes its National Civil Defense warning platform offline after suspected hackers send an unauthorized alert to mobile phones in several states (Mariana Catacci/CNN)
1 min read •
startup
Inside Palantir's fight to save its £330M, seven-year contract with NHS England, as public and political pressure grows to end the deal via a 2027 break clause (Financial Times)
1 min read •